Included Health filed its S-1 for an IPO that never happened. Its CEO said the company went heads-down to reach profitability and sales growth.

Over $32 billion worth of shares from 82 companies will become tradable from January to April 2025 as lock-in periods end.

Nasdaq Inc. Chief Executive Officer Adena Friedman said she expects a strong environment for initial public offerings in the second quarter and balance of 2025 as investors gain confidence from ...

JSW Steel: Extends acquisition deal's long stop date for Minas ... Agarwal's Healthcare: The IPO opens for subscription with an issue size of Rs 3,027.2 crore. Price band: Rs 382 to Rs 402 per share.

Metsera is aiming to put its weight loss drug MET-097i, which boasts of a longer half-life, through Phase III trials.

Metsera (MTSR), which is developing ultra-long-acting drugs for the treatment of obesity, has set terms for an upsized $275M initial public offering. Read more here.

Metsera, which is developing weight-loss drugs, said on Monday it is seeking a valuation of up to $1.78 billion in its U.S.

Metsera Inc. is seeking to raise $292 million in an initial public offering, joining a clutch of health-care firms set to ...

Tech companies' actions are raising questions about whether prioritising higher-paying customers will leave enough power for ...